Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (0)
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Koji Haratani, M.D., Ph.D.
Concepts (190)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
1-Alkyl-2-acetylglycerophosphocholine Esterase
5'-Nucleotidase
Acrylamides
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Albumins
Analgesics, Opioid
Animals
Anti-Bacterial Agents
Antibodies, Bacterial
Antibodies, Monoclonal
Antibodies, Neutralizing
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Biological Transport
Biomarkers, Pharmacological
Biopsy
Borrelia
Borrelia Infections
Breast Neoplasms
Bronchoalveolar Lavage Fluid
Bronchoscopy
Camptothecin
Carbazoles
Carboplatin
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Carrier Proteins
Catechol O-Methyltransferase
CD8-Positive T-Lymphocytes
Ceftriaxone
Cell Line
Cell Line, Tumor
Cell Proliferation
Cell Survival
Cell Transformation, Neoplastic
Chemotherapy, Adjuvant
Cholangitis
Cisplatin
Clinical Trials, Phase II as Topic
Cohort Studies
Colorectal Neoplasms
Cytoplasm
Disease Models, Animal
Disease Progression
Disease-Free Survival
DNA Topoisomerases, Type I
Down-Regulation
Doxycycline
Drug Administration Schedule
Drug Compounding
Drug Resistance, Neoplasm
Drug Therapy, Combination
Dyneins
Esophageal Neoplasms
Exodeoxyribonucleases
Extracellular Signal-Regulated MAP Kinases
Facial Paralysis
Fatal Outcome
Female
Fluorescence Recovery After Photobleaching
Fluorouracil
Follow-Up Studies
Gene Amplification
Gene Expression
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Genes, ras
Genetic Predisposition to Disease
Genetic Testing
Genital Neoplasms, Male
Genomics
Genotype
HCT116 Cells
Head and Neck Neoplasms
Hepatitis
High-Throughput Nucleotide Sequencing
Histocompatibility Antigens Class I
HT29 Cells
Humans
Immune System Diseases
Immunoconjugates
Immunohistochemistry
Immunologic Factors
Immunomodulation
Immunotherapy
Incidence
Indoles
Inhibitor of Apoptosis Proteins
Injections, Intravenous
Intercellular Signaling Peptides and Proteins
Interferons
Japan
Kaplan-Meier Estimate
Killer Cells, Natural
Leukocytes
Ligands
Liver
Lung
Lung Neoplasms
Lyme Neuroborreliosis
Lymphatic Metastasis
Lymphocytes
Lymphocytes, Tumor-Infiltrating
Male
MAP Kinase Signaling System
Maytansine
Melanoma, Experimental
Membrane Proteins
Meningitis, Bacterial
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Nude
Microtubule-Associated Proteins
Microtubules
Middle Aged
Molecular Targeted Therapy
Monitoring, Immunologic
Morphine
Multicenter Studies as Topic
Multivariate Analysis
Mutation
Neoadjuvant Therapy
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasms
Neoplasms, Experimental
Neoplasms, Unknown Primary
Neuregulin-1
Neurons
Neutrophils
Oncogene Protein v-akt
Oxycodone
Paclitaxel
Paget Disease, Extramammary
Pain
Patient Selection
Phenotype
Phosphatidylinositol 3-Kinases
Phosphoproteins
Phosphorylation
Piperazines
Piperidines
Plasma Exchange
Pneumonia
Prognosis
Prospective Studies
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins c-met
Proto-Oncogene Proteins p21(ras)
Pyridines
Pyrimidines
Quinazolines
Receptor Protein-Tyrosine Kinases
Receptor, erbB-2
Receptor, erbB-3
Recombinant Fusion Proteins
Renal Dialysis
Retrospective Studies
Risk Assessment
Risk Factors
Safety
Selective Estrogen Receptor Modulators
Sequence Analysis, DNA
Severity of Illness Index
Signal Transduction
Single-Cell Analysis
Stomach Neoplasms
Survival Analysis
Survival Rate
Swine
Tamoxifen
Taxoids
Time Factors
T-Lymphocytes, Cytotoxic
Topoisomerase I Inhibitors
Treatment Outcome
Tubulin
Tumor Burden
Tumor Cells, Cultured
Tumor Microenvironment
Xenograft Model Antitumor Assays
Haratani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (190)
Derived automatically from this person's publications.
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Neoplasms, Unknown Primary
Receptor, erbB-3
Biomarkers, Pharmacological
Explore
_
Co-Authors (11)
People in Profiles who have published with this person.
Barbie, David
Paweletz, Cloud
Lizotte, Patrick
Fujimoto, Daichi
Mahadevan, Navin
Explore
_
Similar People (60)
People who share similar concepts with this person.
Christiani, David
Sequist, Lecia
Gainor, Justin
Shaw, Alice
Costa, Daniel
Explore
_
Same Department
People in same department with this person.
Ardeljan, Daniel
Fang, Teng
Gehrke, Andrew
Schavgoulidze, Anais
Stover, Elizabeth
Explore
_